Credit Agricole’s Acadia Pharmaceuticals ACAD Stock Holding History

Credit Agricole’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,500	Closed	-$42.7K	–	1108
2024 Q1	$42.7K	Hold	2,500	–	–	﹤0.01%	802
2023 Q4	$78.3K	Hold	2,500	–	–	﹤0.01%	766
2023 Q3	$52.1K	Hold	2,500	–	–	﹤0.01%	780
2023 Q2	$59.9K	Hold	2,500	–	–	﹤0.01%	521
2023 Q1	$47K	Hold	2,500	–	–	﹤0.01%	505
2022 Q4	$39.8K	Hold	2,500	–	–	﹤0.01%	540
2022 Q3	$41K	Hold	2,500	–	–	﹤0.01%	528
2022 Q2	$35K	Hold	2,500	–	–	﹤0.01%	533
2022 Q1	$61K	Hold	2,500	–	–	﹤0.01%	519
2021 Q4	$58K	Hold	2,500	–	–	﹤0.01%	512
2021 Q3	$42K	Hold	2,500	–	–	﹤0.01%	517
2021 Q2	$61K	Hold	2,500	–	–	﹤0.01%	475
2021 Q1	$65K	Hold	2,500	–	–	﹤0.01%	423
2020 Q4	$134K	Hold	2,500	–	–	﹤0.01%	339
2020 Q3	$103K	Hold	2,500	–	–	0.01%	323
2020 Q2	$121K	Hold	2,500	–	–	0.01%	281
2020 Q1	$106K	Hold	2,500	–	–	0.01%	280
2019 Q4	$107K	Hold	2,500	–	–	0.01%	269
2019 Q3	$90K	Hold	2,500	–	–	﹤0.01%	355
2019 Q2	$67K	Hold	2,500	–	–	﹤0.01%	360
2019 Q1	$67K	Hold	2,500	–	–	﹤0.01%	367
2018 Q4	$40K	Hold	2,500	–	–	﹤0.01%	403
2018 Q3	$52K	Hold	2,500	–	–	﹤0.01%	377
2018 Q2	$38K	Buy	+2,500	New	+$44.6K	﹤0.01%	343
2016 Q4	–	Sell	-4,329	Closed	-$138K	–	1459
2016 Q3	$138K	Buy	+4,329	New	+$147K	﹤0.01%	1507

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Credit Agricole's ACAD Position: Q2 2024 in Review

Credit Agricole sold out of Acadia Pharmaceuticals (ACAD) in Q2 2024, closing a stake of 2,500 shares — an estimated $42.7K sold.

Credit Agricole first reported a position in ACAD in Q3 2016 and held it in 25 quarters. The position peaked at $138K in Q3 2016. 264 funds tracked by Wall St. Rank hold ACAD as of Q2 2024.

Credit Agricole reported no remaining Acadia Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Credit Agricole sold 2,500 Acadia Pharmaceuticals shares in Q2 2024, an estimated $42.7K.
Credit Agricole first reported a position in Acadia Pharmaceuticals in Q3 2016 and held it in 25 quarters.
Credit Agricole's Acadia Pharmaceuticals position peaked at $138K in Q3 2016.
264 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2024.

Based on Credit Agricole's 13F filing for Q2 2024, filed 13 Aug 2024.